Senior Expert Pharmacovigilance System Inspector
Pharmacovigilance Executive Directorate, Saudi Food and Drug Authority., Saudi Arabia
Hammad A. Al Dali has a Bachelor of Pharmaceutical Science (B. Pharm) from King Saud University (KSU) in 2010 and a Master's degree in Public Health (MPH) from King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) in 2020.
Currently, Hammad A. Al Dali works in the Saudi FDA, with ten years of experience as a Senior Expert Pharmacovigilance system inspector for the Global, regional, and local pharmaceutical companies in Saudi Arabia at the National Pharmacovigilance and Drug Safety Center. He started his career in SFDA as a senior adverse drug reaction assessor until he became a Senior Expert in Pharmacovigilance systems.
Hammad is a Saudi FDA representative in
1. National Blood Banks - Council Saudi Health Commission (Hemovigilance).
2. Vaccine Safety Network (VSN).
3. Team leader for public awareness about vaccine safety and efficacy.
Hammad worked for four years in a security force hospital (SFHP) as a pharmacist staff and had trained in several drug safety, pharmacovigilance, clinical trials, and vaccine efficacy and safety.